Active Ingredient(s):Cytarabine, ARA-C FDA Approved: * December 30, 1998 Pharm Company: *SICOR PHARMS Category:Cancer
Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma. It is given by injection into a vein, under the skin, or into the cerebrospinal fluid. There is a liposomal formulation for which there is tentative evidence of better outcomes in lymphoma involving the meninges.
* May have multiple approval dates, manufacturers, or labelers.